Skip to main content
Clinical Trials/NL-OMON48033
NL-OMON48033CompletedNot Applicable

Transperineal Laser Ablation for Focal Prostate Cancer: Safety and Ablative Efficacy evaluation using post-radical Prostatectomy Histological Analysis - TPLA for PCa

Academisch Medisch Centrum0 sites15 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - *40 years of age
  • - Histopathological confirmed organ-confined prostate cancer
  • - Indication for a radical prostatectomy
  • - Prostate volume *40mL
  • - Ability of the patient to stop anticoagulant therapy according to standard
  • hospital pre-operative protocol
  • - Signed informed consent

Exclusion Criteria

  • - Prior or concurrent treatment for prostate cancer (biologicals, chemotherapy,
  • radiotherapy)
  • - Inability or unwillingness to tolerate temporary discontinuation of
  • anticoagulation or anti-platelet therapy
  • - Other conditions / status

Investigators

Similar Trials